Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

355 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intralymphatic Immunotherapy: Update and Unmet Needs.
Senti G, Freiburghaus AU, Larenas-Linnemann D, Hoffmann HJ, Patterson AM, Klimek L, Di Bona D, Pfaar O, Ahlbeck L, Akdis M, Weinfeld D, Contreras-Verduzco FA, Pedroza-Melendez A, Skaarup SH, Lee SM, Cardell LO, Schmid JM, Westin U, Dollner R, Kündig TM. Senti G, et al. Among authors: akdis m. Int Arch Allergy Immunol. 2019;178(2):141-149. doi: 10.1159/000493647. Epub 2018 Nov 2. Int Arch Allergy Immunol. 2019. PMID: 30391954 Free article. Review.
A major allergen gene-fusion protein for potential usage in allergen-specific immunotherapy.
Kussebi F, Karamloo F, Rhyner C, Schmid-Grendelmeier P, Salagianni M, Mannhart C, Akdis M, Soldatova L, Markovic-Housley Z, Von Beust BR, Kündig T, Kemeny DM, Blaser K, Crameri R, Akdis CA. Kussebi F, et al. Among authors: akdis m, akdis ca. J Allergy Clin Immunol. 2005 Feb;115(2):323-9. doi: 10.1016/j.jaci.2004.11.041. J Allergy Clin Immunol. 2005. PMID: 15696088
Advances in allergen-specific immunotherapy.
Verhagen J, Taylor A, Akdis CA, Akdis M. Verhagen J, et al. Among authors: akdis m, akdis ca. Expert Opin Biol Ther. 2005 Apr;5(4):537-44. doi: 10.1517/14712598.5.4.537. Expert Opin Biol Ther. 2005. PMID: 15934831 Review.
Targets in allergy-directed immunotherapy.
Verhagen J, Taylor A, Akdis M, Akdis CA. Verhagen J, et al. Among authors: akdis m, akdis ca. Expert Opin Ther Targets. 2005 Apr;9(2):217-24. doi: 10.1517/14728222.9.2.217. Expert Opin Ther Targets. 2005. PMID: 15934911 Review.
Are regulatory T cells the target of venom immunotherapy?
Jutel M, Akdis M, Blaser K, Akdis CA. Jutel M, et al. Among authors: akdis m, akdis ca. Curr Opin Allergy Clin Immunol. 2005 Aug;5(4):365-9. doi: 10.1097/01.all.0000173784.81024.7a. Curr Opin Allergy Clin Immunol. 2005. PMID: 15985821 Review.
Cytokine and antibody responses in birch-pollen-allergic patients treated with genetically modified derivatives of the major birch pollen allergen Bet v 1.
Gafvelin G, Thunberg S, Kronqvist M, Grönlund H, Grönneberg R, Troye-Blomberg M, Akdis M, Fiebig H, Purohit A, Horak F, Reisinger J, Niederberger V, Akdis CA, Cromwell O, Pauli G, Valenta R, van Hage M. Gafvelin G, et al. Among authors: akdis m, akdis ca. Int Arch Allergy Immunol. 2005 Sep;138(1):59-66. doi: 10.1159/000087358. Epub 2005 Aug 11. Int Arch Allergy Immunol. 2005. PMID: 16103688 Clinical Trial.
Prevention of allergy by a recombinant multi-allergen vaccine with reduced IgE binding and preserved T cell epitopes.
Karamloo F, Schmid-Grendelmeier P, Kussebi F, Akdis M, Salagianni M, von Beust BR, Reimers A, Zumkehr J, Soldatova L, Housley-Markovic Z, Müller U, Kündig T, Kemeny DM, Spangfort MD, Blaser K, Akdis CA. Karamloo F, et al. Among authors: akdis m, akdis ca. Eur J Immunol. 2005 Nov;35(11):3268-76. doi: 10.1002/eji.200425522. Eur J Immunol. 2005. PMID: 16206231 Free article.
T regulatory cells in allergen-specific immunotherapy.
Verhagen J, Taylor A, Blaser K, Akdis M, Akdis CA. Verhagen J, et al. Among authors: akdis m, akdis ca. Int Rev Immunol. 2005 Sep-Dec;24(5-6):533-48. doi: 10.1080/08830180500371173. Int Rev Immunol. 2005. PMID: 16318994 Review.
355 results